NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Voyager Biomedical

Voyager Biomedical

Private
Houston, TexasHealthcare & Life Scienceshttp://www.voyagerbiomedical.com/

Last Round

Series A

Apr 4, 2025

Total Funding Raised

$5.82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Voyager Biomedical is a medical device company that develops novel vascular access solutions, including the VenaSure cannulation device, to improve the lives of dialysis patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hemodialysisvascular accessmedical deviceend-stage renal diseaseESRDcannulationimplantable devicedialysis accessfistula careclinical trialsnephrologyvascular surgeryinterventional radiologydialysis hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Voyager Biomedical Comparables

Compare Voyager Biomedical with similar companies based on industry and business-model similarity.

Voyager Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aperture Biomedical
85%
VenoStent
85%
Xeltis
77%

Voyager Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 4, 2025
AcceleratorSep 27, 2017
AcceleratorAug 10, 2016
GrantMay 20, 2016

Voyager Biomedical Investors

Notable investors and investment history

Voyager Biomedical investors
InvestorRounds
MedTech InnovatorAccelerator, Series A
NIH RADxSeries A
Texas Medical CenterAccelerator, Series A
Houston Angel NetworkSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 265% MoM.

  • May 18, 2026

    Monthly visitors increased 1118% MoM, reaching 268.

Voyager Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Voyager Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Voyager Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range8
Year Founded2016
Last FundingApr 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.